Key facts
- It has raised $50K; the latest was Seed Round in Sep 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, VentureWell, Maine Venture Fund, Caelestinus — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Coredio
- ·The full record, as it builds
Funding rounds
No funding rounds for Coredio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coredio
Operator of a noninvasive diagnostics and remote patient monitoring SaaS platform designed to avoid unnecessary escalation of care for heart failure patients. The company's platform leverages available cardiologist devices for central blood pressure and cardiac output for detecting early signs of abnormalities, enabling doctors, cardiologists, and patients with personalized cardiovascular monitoring and patients to have better health and fewer readmissions.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2023
- Employees
- 4
- Website
- coredio-ai.com/
- Ownership
- Privately Held (backing)
Coredio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coredio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coredio in its N-PORT filings yet. We sweep new filings monthly.